Torrey Path

Torrey Path is a San Diego-based biotechnology company focused on the discovery and development of next-generation small molecule precision medicines for oncology. The company was founded by the core scientific and executive leadership team from Turning Point Therapeutics, bringing deep expertise in structure-based drug design and kinase inhibitor development. Torrey Path leverages its experience in macrocyclic chemistry and precision medicine to design highly selective therapies that address unmet needs and resistance mechanisms in cancer. The company aims to improve patient outcomes by targeting specific genetic drivers of disease with optimized pharmacological profiles.